Tissue-selective inhibition of prostaglandin and thromboxane synthesis in man: investigative and therapeutic implications.
D000991:Antithrombins / Q000494:pharmacology; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000502:physiology; D007700:Kinetics; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D013467:Sulindac / Q000494:pharmacology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000991:Antithrombins; D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D012459:Salicylates; D013467:Sulindac; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D001241:Aspirin